Reaktionsgleichung
[CH:1]([C:4]1[S:5][CH:6]=[C:7]([CH2:9][NH:10][CH3:11])[N:8]=1)([CH3:3])[CH3:2].[CH3:12][O:13][C:14](=[O:32])[C@H:15]([CH:29]([CH3:31])[CH3:30])[NH:16][C:17]([O:19]C1C=CC([N+]([O-])=O)=CC=1)=O.C(N(CC)CC)C>C1COCC1.CN(C)C1C=CN=CC=1>[CH3:12][O:13][C:14](=[O:32])[C@H:15]([CH:29]([CH3:30])[CH3:31])[NH:16][C:17]([N:10]([CH3:11])[CH2:9][C:7]1[N:8]=[C:4]([CH:1]([CH3:2])[CH3:3])[S:5][CH:6]=1)=[O:19]Komponenten
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
A solution of 15.7 g (92 mmol) of 2-isopropyl-4-(((N-methyl)amino)methyl)thiazole in 200 ml of THF was combined with a solution of 20.5 g (69 mmol) of N-(((4-nitrophenyl)oxy)carbonyl)-L-valine methyl ester. The resulting solution was treated with 1.6 g of 4-dimethylaminopyridine and 12.9 ml (92 mmol) of triethylamine, heated at reflux for 2 h, allowed to cool, and concentrated in vacuo. The residue was taken up in CH2Cl2, washed extensively with 5% aqueous K2CO3, dried over Na2SO4, and concentrated in vacuo. The resulting product mixture was purified by silica gel chromatography using chloroform as an eluent to provide 16.3 g (54%) of the desired compound. 1H NMR (DMSO-d6) δ0.88 (d, J=7 Hz, 3H), 0.92 (d, J=7 Hz, 3H), 1.32 (d, J=7 Hz, 3H), 2.05 (octet, J=7 Hz, 1H), 2.86 (s, 3H), 3.25 (heptet, J=7 Hz, 1H), 3.61 (s, 3H), 3.96 (dd, J=8, 7 Hz, 1H), 4.44 (AA', 2H), 6.58 (d, J=8 Hz, 1H), 7.24 (s, 1H). Mass spectrum: (M+H)+ =328.
Aufarbeitung
- temperatureheated
- temperatureat reflux for 2 h
- temperatureto cool
- concentrationconcentrated in vacuo
- washwashed extensively with 5% aqueous K2CO3
- dry with materialdried over Na2SO4
- concentrationconcentrated in vacuo
- customThe resulting product mixture was purified by silica gel chromatography
Quellen und Nachweise
- ORD-Eintrag
- ord-c904e12c879447a79d5c34425e515e61
- Quelldatensatz
- uspto-grants-1997_04
- Patentnummer
- US05616720
Verknüpfte Notizen
Wird geladen…